These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 28049580)

  • 21. Identification of microRNAs differentially expressed between lung squamous cell carcinoma and lung adenocarcinoma.
    Hamamoto J; Soejima K; Yoda S; Naoki K; Nakayama S; Satomi R; Terai H; Ikemura S; Sato T; Yasuda H; Hayashi Y; Sakamoto M; Takebayashi T; Betsuyaku T
    Mol Med Rep; 2013 Aug; 8(2):456-62. PubMed ID: 23759980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of microRNAs in basal cell carcinoma.
    Sand M; Skrygan M; Sand D; Georgas D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG
    Br J Dermatol; 2012 Oct; 167(4):847-55. PubMed ID: 22540308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA signature identification of retinoblastoma and the correlations between differentially expressed miRNAs during retinoblastoma progression.
    Yang Y; Mei Q
    Mol Vis; 2015; 21():1307-17. PubMed ID: 26730174
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.
    Zou H; Molina JR; Harrington JJ; Osborn NK; Klatt KK; Romero Y; Burgart LJ; Ahlquist DA
    Int J Cancer; 2005 Sep; 116(4):584-91. PubMed ID: 15825175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Five miRNAs considered as molecular targets for predicting neuroglioma.
    Yang H; Wang Y
    Tumour Biol; 2016 Jan; 37(1):1051-9. PubMed ID: 26269115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA 345, a methylation-sensitive microRNA is involved in cell proliferation and invasion in human colorectal cancer.
    Tang JT; Wang JL; Du W; Hong J; Zhao SL; Wang YC; Xiong H; Chen HM; Fang JY
    Carcinogenesis; 2011 Aug; 32(8):1207-15. PubMed ID: 21665895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNA microarray analysis identifies miR-4429 and miR-4689 are potential diagnostic biomarkers for biliary atresia.
    Dong R; Shen Z; Zheng C; Chen G; Zheng S
    Sci Rep; 2016 Feb; 6():21084. PubMed ID: 26879603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide analysis of miRNA and mRNA transcriptomes during amelogenesis.
    Yin K; Hacia JG; Zhong Z; Paine ML
    BMC Genomics; 2014 Nov; 15(1):998. PubMed ID: 25406666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
    Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
    Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of integrated-signature miRNAs in esophageal cancer.
    Zhang HC; Tang KF
    Cancer Med; 2017 Aug; 6(8):1893-1903. PubMed ID: 28707457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated analysis of DNA methylation and microRNA regulation of the lung adenocarcinoma transcriptome.
    Du J; Zhang L
    Oncol Rep; 2015 Aug; 34(2):585-94. PubMed ID: 26035298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data.
    Sun Y; Jia X; Hou L; Liu X
    Urology; 2016 Aug; 94():313.e1-6. PubMed ID: 27179774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying the miRNA signature associated with survival time in patients with lung adenocarcinoma using miRNA expression profiles.
    Yerukala Sathipati S; Ho SY
    Sci Rep; 2017 Aug; 7(1):7507. PubMed ID: 28790336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.
    Liu W; Dong Z; Liang J; Guo X; Guo Y; Shen S; Kuang G; Guo W
    Cancer Invest; 2016 Nov; 34(10):506-516. PubMed ID: 27791400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A; Jung M; Mollenkopf HJ; Wagner I; Stephan C; Jentzmik F; Miller K; Lein M; Kristiansen G; Jung K
    Int J Cancer; 2010 Mar; 126(5):1166-76. PubMed ID: 19676045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma.
    Yang M; Liu R; Sheng J; Liao J; Wang Y; Pan E; Guo W; Pu Y; Yin L
    Oncol Rep; 2013 Jan; 29(1):169-76. PubMed ID: 23124769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis-related miRNA bioinformatics screening of lung adenocarcinoma and its clinical significance].
    Zhang HM; Yang B; Chen HF; Chi XH; Xi YB; Chen XM; Guo B; He PF; Lu XC
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Jun; 34(6):530-535. PubMed ID: 31032588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic alternations of microRNAs and DNA methylation contribute to gestational diabetes mellitus.
    Zhu W; Shen Y; Liu J; Fei X; Zhang Z; Li M; Chen X; Xu J; Zhu Q; Zhou W; Zhang M; Liu S; Du J
    J Cell Mol Med; 2020 Dec; 24(23):13899-13912. PubMed ID: 33085184
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Screening key genes and miRNAs in early-stage colon adenocarcinoma by RNA-sequencing.
    Liu J; Liu F; Li X; Song X; Zhou L; Jie J
    Tumour Biol; 2017 Jul; 39(7):1010428317714899. PubMed ID: 28714374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.